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Summary
Polo-like kinase 4 (Plk4) is a conserved master regulator of
centriole assembly [1]. Previously, we found thatDrosophila
Plk4 protein levels are actively suppressed during inter-
phase [2]. Degradation of interphase Plk4 prevents centriole
overduplication and ismediated by the ubiquitin-ligase com-
plex SCFSlimb/bTrCP [3, 4]. Since Plk4 stability depends on its
activity [5, 6], we studied the consequences of inactivating
Plk4 or perturbing its phosphorylation state within its
Slimb-recognition motif (SRM). Mass spectrometry of in-
vitro-phosphorylated Plk4 and Plk4 purified from cells
reveals that it is directly responsible for extensively auto-
phosphorylating and generating its Slimb-binding phospho-
degron. Phosphorylatable residues within this regulatory
region were systematically mutated to determine their im-
pact on Plk4 protein levels and centriole duplication when
expressed in S2 cells. Notably, autophosphorylation of a
single residue (Ser293) within the SRM is critical for Slimb
binding and ubiquitination. Our data also demonstrate that
autophosphorylation of numerous residues flanking S293
collectively contribute to establishing a high-affinity binding
site for SCFSlimb. Taken together, our findings suggest that
Plk4 directly generates its own phosphodegron and can do
so without the assistance of an additional kinase(s).
Results and Discussion
Centriole overduplication is prevented by limiting centriole
duplication to one occurrence per cell cycle, and while
numerous proteins affect centriole number, much remains to
be discovered about their coordination and regulation [7]. A
key component is Polo-like kinase 4 (Plk4)/Sak, a conserved
master regulator of centriole duplication [8, 9]. During inter-
phase, Plk4 is degraded, which prevents centriole overdupli-
cation [3, 4]. Features of this degradation mechanism support
the following model: Plk4 homodimerizes and phosphorylates
several residues within a hydroxyl-rich region called the
downstream regulatory element (DRE) (Figure 1A), although
precise sites of phosphorylation are unknown [5, 6, 10, 14].
Embedded within the DRE is a conserved Slimb-recognition
motif (SRM; DpSGXXpT) whose serine/threonine residues*Correspondence: gcrogers@email.arizona.eduare phosphorylated, generating a phosphodegron recognized
by the F box protein Slimb in Drosophila or b-TrCP in humans
[3–6, 15]. F box proteins are substrate-targeting subunits of
the SCF ubiquitin ligase that ubiquitinates Plk4, marking the
kinase for proteasomal degradation [3–6, 15].
Several important questions concerning Plk4 regulation
remain to be answered. First, although purified Plk4 exten-
sively phosphorylates its DRE in vitro [5], the specific phos-
phorylation sites required for Slimb recognition have not
been defined. Second, it is not known which specific residues
are autophosphorylated. Third, it is not clear whether the Plk4
phosphodegron is generated directly by autophosphorylation
or whether another unidentified kinase is required [6, 16, 17].
Thus, important features of Plk4 downregulation remain to
be discovered. To address these mechanistic unknowns,
we examined which DRE residues are autophosphorylated,
explored the consequences of inactivating Plk4, and deter-
mined what happens to Plk4 stability when the normal DRE
phosphorylation pattern is perturbed.
Previous work has shown that kinase-dead Plk4 (KD-Plk4) is
stable when expressed in cells, suggesting that kinase activity
precedes its degradation [2, 5, 6, 18, 19]. KD-Plk4 expression
also induces centriole overduplication in tumor-derived cell
lines when endogenous Plk4 is present [5, 6, 9]. The latter
result is counterintuitive, but it was proposed that the SRM
within KD-Plk4 is phosphorylated in trans after heterodimeriz-
ing with endogenous Plk4 and that phosphorylated KD-Plk4
then sequesters b-TrCP/Slimb, decreasing the available
b-TrCP. Thus, endogenous Plk4 levels would increase and
stimulate centriole amplification [6].
We examined whether centriole amplification is a universal
consequence of KD-Plk4 expression or unique to transformed
cells. We expressed metallothionein-inducible KD-Plk4 and
other Plk4-EGFP constructs in S2 cells, an immortalized
Drosophila cell line. After 3 days of expression, centrioles
were visualized by immunostaining for PLP [20], a centriole
protein that coats the surface of mature centrioles [21],
and manually counted. Due to their small size, mother and
daughter centrioles cannot be distinguished within an
engaged pair using standard light microscopy inmost fly cells.
Nevertheless, the number of PLP spots is an accurate readout
of centriole loss (fewer than two spots) and amplification (more
than two spots) in these cells [2–4, 8, 10]. As expected, all Plk4
constructs localized to centrioles, though KD-Plk4 also formed
small puncta in the cytoplasm that lacked PLP (Figure 1B).
Under low-expression conditions, only nondegradable Plk4
Slimb-binding mutant (SBM; a S293A/T297A double mutation
within the SRM that blocks Slimb binding [3, 4]) significantly
increased the percentage of cells with more than two centri-
oles (Figure 1C), as shown previously [3, 4]. However, under
high-expression conditions, wild-type Plk4 (WT-Plk4) induced
significant centriole amplification, consistent with the model
that increased Plk4 activity drives centriole overduplication
(Figure 1C). Surprisingly, high expression of KD-Plk4 had the
opposite effect: the percentage of cells with fewer than two
centrioles significantly increased (Figure 1C). Therefore, our
results suggest that KD-Plk4 behaves as a dominant negative
in S2 cells, inhibiting centriole duplication. A similar result was
Figure 1. High Expression of Kinase-Dead Plk4 Blocks Centriole Duplication by Preventing Asterless Targeting to Centrioles
(A) Linear map of Drosophila Plk4 showing functional and structural domains. The downstream regulatory element (DRE) is a span of approximately
50 amino acids containing the phylogenetically conserved Slimb-recognition motif (SRM). Plk4 contains three Polo boxes (PBs) [10]. PB1 and PB2 comprise
the Asl-binding region [10–13].
(B) S2 cells coexpressing the indicated Plk4-EGFP construct (green) and Nlp-EGFP (a nuclear protein used as a transfection marker; green nuclei) were
immunostained for PLP (red) to mark centrioles. DNA is in blue. Expression of Plk4 constructs was induced with 50 mM CuSO4. KD-Plk4 targets centrioles
(arrowhead) but also forms cytoplasmic punctate aggregates (arrows). The scale bar represents 5 mm.
(C) Transfected S2 cells were induced to express Plk4-EGFP constructs at low (50 mMCuSO4) or high (1mMCuSO4) levels for 3 days and immunostained for
PLP, and their centrioles were counted. Centriole amplification (a significant, increased frequency of more than two centrioles per cell) occurs in cells
expressing SBM-Plk4 (p = 0.0001) or a high level of WT-Plk4 (p = 0.0002). In contrast, centriole duplication is inhibited (a significant, increased frequency
of fewer than two centrioles per cell) in cells expressing a high level of KD-Plk4 (p < 0.0001) but not KD-Plk4-DPB1-PB2 (p = 0.29). At least three experiments
were performed per construct (n = 600 cells/construct). Error bars indicate the SEM.
(D) S2 cells coexpressing the indicated Plk4-EGFP construct (green) and the transfection marker, Nlp-EGFP (green nuclei), were immunostained for PLP
(red) and Asterless (blue; bottom row). DNA is in blue (top row). Expression of Plk4 constructs was inducedwith 1mMCuSO4. The scale bar represents 5 mm.
(E) Anti-GFP immunoprecipitates from S2 cell lysates transiently expressing the indicated Plk4-EGFP construct (or control GFP) were probed for GFP and
endogenous Asterless. Note that coprecipitating Asl is absent in the control and KDDPB1-PB2 samples.
See also Figure S1.
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embryos [22].
Because KD-Plk4 formed puncta within the cytoplasm, we
reasoned that KD-Plk4 overexpression might perturb localiza-
tion of essential centriole components, such as the Plk4-
binding protein Asterless (Asl) [11–13]. To test this, we used
anti-Asl antibodies (Figure S1A available online) to examine
the association of Asl with KD-Plk4 and centrioles. Endoge-
nous Asl coimmunoprecipitated with WT-Plk4-EGFP and KD-
Plk4-EGFP but not control EGFP (Figure 1E). Unlike WT-Plk4,
high expression of KD-Plk4 completely blocked Asl localiza-
tion to centrioles (Figure 1D). This effect was directly due to
KD-Plk4 binding because expression of a mutant form of
KD-Plk4 lacking the Asl-binding domain (KD-Plk4-DPB1-
PB2-EGFP) (Figure 1E) [10–13] displayed normal centriole
numbers and Asl localization (Figures 1C and 1D). Theseresults suggest that KD-Plk4 blocks centriole duplication by
sequestering Asl, thus preventing Asl from localizing endoge-
nous Plk4 to centrioles (Figures S1B and S1C). The disparity in
KD-Plk4 overexpressed in human cancer and Drosophila cells
might reflect a fundamental difference in Plk4 regulation in
these systems.
Previous work in transformed cells suggests that Plk4
homodimerizes and trans-phosphorylates to induce its degra-
dation [5, 6]. To test whether trans-phosphorylation is a
prerequisite for SCFSlimb recognition, we coexpressed EGFP-
and Myc-tagged KD-Plk4 and WT-Plk4 in cells and evaluated
their relative stabilities using quantitative immunoblotting. As
expected, Plk4 was almost undetectable in cells coexpressing
two WT constructs (Figure 2A, lane 1). (We verified WT-
Plk4-Myc expression by depleting Slimb to stabilize this pro-
tein [Figure S2A].) In contrast, KD-Plk4 is strongly stabilized
Figure 2. Plk4 Is Destabilized by trans-Autophosphorylation and Directly Autophosphorylates Its SRM In Vitro
(A) The relative protein stabilities of different combinations of Plk4 constructs were analyzed by immunoblotting lysates of S2 cells transiently coexpressing
the indicated EGFP- and Myc-tagged Plk4 constructs and Nlp-EGFP (used as a loading control and expressed under its endogenous promoter). Anti-Myc
immunoblots are shown at short and long exposures.
(B) Anti-GFP immunoprecipitates (IPs) were prepared from lysates of S2 cells transiently expressing 3xFLAG-ubiquitin and the indicated combinations of
EGFP- andMyc-tagged Plk4 constructs. Blots of the IPswere probedwith anti-GFP, anti-FLAG, and anti-Slimb antibodies. Note that robust ubiquitination of
Plk4 corresponds to the presence of endogenous Slimb and that coexpression of KD-Plk4 (lane 2) prevents phosphorylation (as indicated by the lack of gel
shift), Slimb binding, and ubiquitination.
(C) Autophosphorylation of Plk4 kinase domain is more efficient as a dimer compared to a monomeric species. Both purified recombinant GST-tagged
(dimeric) human Plk4 kinase domain plus SRM (lane 1) and monomeric kinase (cleaved of its GST tag; lane 2) autophosphorylate in vitro. Plk4 does not
phosphorylate purified GST (lane 3). Top: Coomassie-stained SDS-PAGE gel. Bottom: corresponding autoradiograph. Equimolar amounts of dimeric
and monomeric kinase were assayed.
(D) The DRE contains a conserved, high percentage (w20%–40%) of hydroxyl amino acids (highlighted) that are potential sites of phosphorylation. These
include the conserved serine and threonine residues within the SRM (boxed).
(E) In vitro phosphorylation sites within the DRE were identified by tandem mass spectrometry (MS-MS) analysis of purified fly His6-Plk4 (amino acid res-
idues 1–317, comprising the kinase and DRE domains) incubated with MgATP. Above the DRE sequence, in vitro phosphorylation sites identified with high
confidence are indicated with a ‘‘P’’ encircled with a solid line; a low-confidence site (S285) is indicated with a ‘‘P’’ encircled with a dashed line. In vivo phos-
phorylation sites within the DRE were identified byMS analysis of full-length Plk4-EGFP immunoprecipitated from S2 cell lysates. Identified in vivo sites are
marked below the DRE sequence. (A very low-confidence site, S271, is notmarked.) At least nine of the hydroxyl residues within the DRE are phosphorylated
in vitro, and seven of these residues are also phosphorylated in vivo (bottom row).
See also Figure S2 and Tables S1 and S2.
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However, KD-Plk4 is clearly less stable when coexpressed
with WT-Plk4 and migrates as a smear on SDS-PAGE (Fig-
ure 2A, lane 2), suggesting that KD-Plk4 has been phosphory-
lated. Therefore, the ability to trans-phosphorylate controls
Plk4 stability.
We tested this further by assaying Slimb association with
Plk4 and its ubiquitination state. To assess Plk4 ubiquitina-
tion, we cotransfected S2 cells with 3xFLAG-Ubiquitin (Ubi).Immunoprecipitation of EGFP-tagged WT-Plk4 retrieved
the second Myc-tagged WT-Plk4 as well as endogenous
Slimb, and both Plk4 proteins were robustly ubiquitinated
(Figure 2B, lane 1, and Figure S2B) while negative control
GFP was not (Figure S2C). In contrast, ubiquitination dimin-
ished when two KD-Plk4 constructs were coexpressed (Fig-
ure 2B, lane 2, and Figure S2B), and, as expected from their
increased stabilities, Slimb failed to associate (Figure 2B,
lane 2).
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dimerization of KD-Plk4 with WT-Plk4 should result in
KD-Plk4’s trans-phosphorylation, ubiquitination, and destabi-
lization (Figure S2B). In this case, KD-Plk4-EGFP now dis-
played the smeary appearance of a phosphorylated species,
associated with Slimb, and was robustly ubiquitinated. (Fig-
ure 2B, lane 3).
The above observations support a conservedmechanism of
degradation whereby trans-phosphorylation within a Plk4
homodimer induces its ubiquitination. We next used an
in vitro system to ask whether dimerization affects Plk4 auto-
phosphorylation. A construct of human Plk4 encoding the
kinase domain and its SRM (amino acids 1–289) was tagged
with GST to induce dimerization. Autophosphorylation of the
dimeric Plk4 and the monomeric kinase (generated by cleav-
age of GST) was compared. Whereas monomeric Plk4 dis-
played some capacity to autophosphorylate, dimeric Plk4
kinase strongly autophosphorylated under the same condi-
tions (Figure 2C, lanes 1 and 2). Phosphorylation was specific,
as monomeric Plk4 did not phosphorylate GST added to
the reaction (Figure 2C, lane 3). Thus, Plk4 dimerization is
an efficient mechanism for trans-phosphorylation and self-
destruction.
Previous studies revealed that Slimb interacts with Plk4
through a phosphorylated motif (the SRM) near the kinase
domain (Figure 2D) [3, 4, 23]. This region of 50 amino acids,
the DRE, contains the SRM, is serine/threonine rich, and is
extensively autophosphorylated in vitro [2, 5]. However, spe-
cific autophosphorylated DRE residues are unknown, and it
is not clear whether Plk4 directly generates its own phospho-
degron to recruit Slimb or whether another kinase is respon-
sible [6, 16, 17]. First, we mapped in vitro autophosphorylated
residues using MS-MS of Drosophila Plk4 containing the
kinase domain and DRE (amino acids 1–317) and identified
ten (of 13 possible) autophosphorylated DRE residues (Figures
2E and S2D and Table S1). Significantly, both SRM residues
S293 and T297 were autophosphorylated, as were eight sites
flanking the SRM.MS-MSwas also used to examine the in vivo
phosphorylation state of the DRE of Plk4-EGFP immunopre-
cipitated from S2 cell lysates. Of the ten residues identified
in vitro, seven were phosphorylated in vivo, including S293
(Figures 2E and S2E and Table S2). Although our results do
not exclude the possibility that additional DRE residues are
autophosphorylated in cells, our findings demonstrate that
Plk4 can directly autophosphorylate its DRE, including the
key SRM residues S293 and T297.
To investigate what impact the phosphorylation states of
DRE residues have on Plk4 stability, wemutated each hydroxyl
residue to alanine within full-length Plk4. To avoid neglecting a
phosphorylated residue not identified in our MS analysis, we
individually mutated all 13 serine/threonine DRE residues (Fig-
ure 3A). Each Plk4-EGFP mutant was expressed in S2 cells,
and quantitative immunoblots were used to measure protein
levels. Unexpectedly, mutation of only one residue, S293,
extensively stabilized Plk4 (Figure 3B). Interestingly, the sec-
ond SRM residue, T297, had only a small impact on Plk4
stability (Figure 3B). Thus, S293 is the key residue for Slimb
recognition, whereas T297 makes a minor contribution. Muta-
tion of other residues downstream of T297A also slightly
increased Plk4 stability compared to WT-Plk4, suggesting
that phosphorylation of these residues may also contribute
to Slimb binding (Figure 3B).
To determine whether mutation of S293 alone blocks
Slimb binding, we performed immunoprecipitations from cellscoexpressing 3xFLAG-Ubi. S293A failed to bind Slimb and
ubiquitination decreased w10-fold, whereas T297A had a
moderate impact (Figures 3C–3E), consistent with the obser-
vation that T297A is slightly more stable than WT-Plk4 (Fig-
ure 3B). Overexposure of the FLAG immunoblot revealed one
persistent ubiquitinated species for S293A and SBM-Plk4 (Fig-
ure 3C), suggesting that an unidentified Slimb-independent
ubiquitin ligase may also regulate Plk4.
Mutations that increase Plk4 stability should induce
centriole amplification [3, 4]. To test this, we expressed Plk4-
EGFP constructs in S2 cells for 3 days and measured centriole
numbers. As expected, both S293A and T297A mutants local-
ized to centrioles (Figure 3F). Whereas S293A significantly
increased centriole number (more than two centrioles per
cell) to an extent nearly identical to SBM-Plk4, T297A did not
produce a significant increase (Figure 3G). Thus, S293 is the
key residue for Slimb recognition, whereas T297 modestly in-
creases the efficiency of Slimb binding but is nonessential.
We next examined whether phosphorylated DRE residues
collectively regulate Plk4 by systematically mutating every hy-
droxyl residue, such that each new Plk4 construct contained a
steadily accumulating number of alaninemutations (Figure 4A).
Mutation of the five residues upstream of S293 had little effect
on Plk4 stability, even when mutated together (Figure 4B,
A1–A5). However, once S293A was included, Plk4 stability
increased significantly (Figure 4B, A6). Plk4mutants with addi-
tional alanine substitutions downstream of S293A did not
significantly elevate levels greater than A6 (Figure 4B, A7–
A12), with the exception of Plk4 harboring all 13 alanine muta-
tions (A13), which displayed an w3-fold average increase in
protein level (compared to A6; p = 0.0001). These results sug-
gest that numerous hydroxyl DRE residues, in combination
with S293, function collectively to recruit Slimb.
Since S293A alone prevents Slimb binding, we predicted
that Plk4 mutants harboring the S293A mutation (A6–A13)
would not bind Slimb and exhibit diminished ubiquitination.
Surprisingly, mutants that include the S276A mutation (A2–
A5) displayed reduced Slimb binding and ubiquitination
compared to WT-Plk4. As expected, mutants of Plk4 lacking
S293 (A6–A13) fail to bind Slimb and are not extensively ubiq-
uitinated (Figure 4C). Therefore, the phosphorylation state of
hydroxyl DRE residues preceding the SRMcan influence Slimb
binding. All A1–A13 mutants also localized properly to centri-
oles and those constructs with increased stability (A6–A13)
increased the percent of cells with more than two centrioles
(Figures 4D and 4E and data not shown). Thus, the trend in
centriole amplification duplicates the trend in Plk4 stability.
The previousmutant series revealed that some hydroxyl res-
idues flanking the SRM contribute to Slimb recognition and
ubiquitination. To examine how these residues regulate Plk4,
we generated a newmutant series that progressively accumu-
lated alanine substitutionswithoutmutating S293 (Figure S3A).
Strikingly, though Plk4 stability is minimally affected by either
the single T297A mutant or the aggregate mutation of the five
hydroxyl residues upstream of the SRM (A5), the combination
of thesemutations (A14) stabilized Plk4 to a level almost 4-fold
greater than T297A, and constructs containing additional mu-
tations downstream of T297A are just as stable (Figure S3B).
Elimination of upstream hydroxyl residues and T297 (A14)
reduced Slimb binding and the extent of ubiquitination by
w50% (Figure S3C), confirming that upstream hydroxyl DRE
residues contribute to Slimb binding. Additional mutations
downstream of the SRM decreased Slimb binding by another
2-fold (Figure S3C, A15–A20), but did not further increase
Figure 3. S293 of the SRM Is the Critical DRE Res-
idue for Slimb Recognition
(A) Thirteen hydroxyl amino acids (red) within the
DRE of full-length fly Plk4 were individually
mutated to alanines and were used to evaluate
the impact of each residue on Plk4 stability and
centriole duplication. S293 and T297 reside within
the SRM (yellow highlight).
(B) Top: anti-GFP immunoblot of lysates prepared
from S2 cells transiently coexpressing the
indicated Plk4-EGFP construct and Nlp-EGFP
(loading control). All Plk4 mutants are single
alanine mutants, except for SBM (a double mutant
of S293A/T297A). Bottom: Plk4-EGFP intensities
were measured by densitometry of the anti-GFP
immunoblot and were normalized with their
respective Nlp-EGFP loading controls. The plotted
values are the normalized Plk4 intensities relative
to the WT-Plk4 treatment.
(C) Anti-GFP immunoprecipitates of lysates pre-
pared from S2 cells transiently expressing
3xFLAG-ubiquitin and the indicated Plk4-EGFP
construct were probed with anti-GFP, anti-FLAG,
and anti-Slimb antibodies. Short and long expo-
sures of the anti-FLAG immunoblot are shown.
(D) Amounts of associated endogenous Slimb
were determined by densitometry of the anti-
Slimb immunoblot and then normalization of the
measurements with the amounts of Plk4-EGFP
present in the IPs. The plotted values are relative
to the WT-Plk4 treatment.
(E) The relative amounts of total Plk4 FLAG-Ubi
were calculated using the densitometry method
described in (D).
(F) S2 cells coexpressing the indicated Plk4-EGFP
construct (green puncta) and Nlp-EGFP (green
nuclei) were immunostained for PLP (red) to
mark centrioles. DNA is in blue. Insets show higher
magnifications of the boxed regions.
(G) The centrioles of S2 cells treated and immuno-
stained as in (F) were counted. Centrioles are
amplified in cells expressing SBM (p < 0.0001) or
S293A (p < 0.0001) but not T297A (p = 0.06). There
is no significant difference in centriole loss (black
bars) in these treatments. Four experiments were
performed per construct (n = 600 cells/construct).
Error bars indicate the SEM.
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residues besides S293 collectively contribute to Slimb binding
and ubiquitination.
To completely isolate the contribution of non-SRM residues
to Plk4 stability, we generated constructs possessing an unal-
tered SRM but with all hydroxyl residues flanking S293/T297
mutated to alanine (Figure S4A). This series showed a clear
pattern: progressively accumulating mutations had little effect
on Plk4 stability until residues downstream of the SRM were
mutated (compare A1–A5 of Figure 4Bwith Figure S4B). There-
fore, mutation of upstream hydroxyl residues has limited
impact on Plk4 stability and only becomes appreciable when
T297 (Figure S3B) and/or downstream residues are also
mutated. As further downstream residues were mutated, pro-
tein levels displayed a near steady increase; this was accom-
panied by an w5-fold reduction in the amount of associated
Slimb (Figures S4B and S4C). All mutants localized to centri-
oles (Figures S3D and S4D and data not shown), and all stabi-
lizing mutations increased centriole numbers (Figures S3E and
S4E). Thus, our findings suggest that the SRM is flanked byphosphorylatable residues that positively regulate Slimb
recognition. Their cumulative effect is substantial as Slimb
binding is inhibited to almost as great an extent by loss of
flanking hydroxyl residues (e.g., A26) as by KD or SBM (Fig-
ure S4C). Even though S293 is required for Slimb binding
(Figure 3C), loss of the other hydroxyl residues can diminish
ubiquitination as strongly as S293A (Figure S3C). Our data
suggest that hydroxyl residues downstream of the SRM (Fig-
ure S4, A21–A26) exert a greater influence on Slimb binding,
Plk4 stability, and centriole duplication than those upstream
of the SRM (Figure 4, A1–A5), although the mechanistic basis
for this is unknown.
Our findings demonstrate that the Plk4 DRE influences
Slimb binding, ubiquitination, and centriole duplication.
Previous studies demonstrated that S293 and T297 are criti-
cal in regulating Plk4 stability [3–6], and our results sup-
port functional roles for other phosphorylatable DRE residues
[5]. A similar study [24] published in this issue also found
that autophosphorylation of DRE residues affects Plk4
stability and centriole numbers. Furthermore, self-regulation
Figure 4. Mutation of All 13 Hydroxyl DRE Residues Display Only a Subtle Difference in Plk4 Stability Compared to the S293A Mutant
(A) Hydroxyl residues (blue) within the DRE were systematically mutated to nonphosphorylatable alanines (red) to generate a series of Plk4 constructs
containing an increasing number of mutations.
(B) Plk4 is stabilized bymutation of residue S293, but this stability is slightly modulated by neighboring phosphorylatable residues within the DRE. Top: anti-
GFP immunoblot of lysates from S2 cells transiently coexpressing the indicated Plk4-EGFP construct and Nlp-EGFP (loading control). Bottom: relative
amounts of Plk4 protein were determined by measurement of the integrated intensities of the Plk4 bands, normalized to their respective loading controls,
and were then plotted relative to the normalized intensity of WT-Plk4. Measurements were obtained from three experiments. Error bars indicate the SEM.
(C) Blots of anti-GFP immunoprecipitates from lysates of S2 cells transiently expressing 3xFLAG-Ubi and the indicated Plk4-EGFP construct were probed
with anti-GFP, anti-FLAG, and anti-Slimb antibodies. Slimb binding is reduced bymutation of upstream DRE serines (A2–A5). As expected, Slimb binding is
eliminated in mutants containing the S293A mutation (A6–A13).
(D) S2 cells coexpressing the indicated Plk4-EGFP plasmid (green puncta) and Nlp-EGFP (green nuclei) were immunostained for PLP to mark centrioles
(red). DNA is in blue.
(E) Expression of stabilized Plk4 mutants increases the percent of cells with excess centrioles (more than two). Centrioles in 100 cells were measured per
construct.
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coexpression of WT-Plk4 converts KD-Plk4 into a Slimb-bind-
ing species and promotes its ubiquitination and degradation in
Drosophila. Moreover, dimerized Plk4 autophosphorylates
in vitro more readily than monomeric Plk4.
Although autophosphorylation is necessary for Plk4 degra-
dation, it was not previously known whether Plk4 directly
generates its own phosphodegron or whether autophosphor-
ylation serves to prime and recruit an additional kinase(s) to
phosphorylate the SRM. The latter is true for the Slimb/
b-TrCP substrates b-catenin, Ci, and Wee1; multiple kinases
sequentially phosphorylate and generate the phosphodegron
in these Slimb/b-TrCP substrates [25–27]. Significantly, a
majority of the Plk4 hydroxyl DRE residues are autophos-
phorylated. Therefore, our data support a model wherebyPlk4 directly generates its phosphodegron unassisted. This
is consistent with our previous RNAi screen of the Drosophila
kinome, which did not reveal the involvement of an additional
kinase in regulating Plk4 levels [2]. Our systematic mutagen-
esis of the DRE indicates that S293 is the critical phosphoresi-
due for Slimb binding and that multiple residues flanking
S293, particularly those downstream, collectively generate a
higher-affinity Slimb-binding region. However, mutation of all
hydroxyl DRE residues except for S293 significantly increases
Plk4 stability, suggesting that phosphorylation of S293 alone
does not promote efficient degradation. Notably, the Plk4
DRE is not the only autophosphorylated region [16]. The
importance of these additional phosphoresidues in regulating
Plk4 activity and/or its association with binding partners re-
mains to be determined.
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